2017;2:986 94. S4.3-31. Malik S, Zhao Y, Budoff M, et al. Coronary artery calcium score for long-term risk classification in individuals with type 2 diabetes and metabolic syndrome from the Multi-Ethnic Study of Atherosclerosis. JAMA Cardiol. 2017;2:1332 40. S4.3-32. Sniderman AD, Tsimikas S, Fazio S. The severe hypercholesterolemia phenotype: clinical diagnosis, management, and emerging thera- pies. J Am Coll Cardiol. 2014;63:1935 47. S4.3-33. Sniderman AD, Williams K, Contois JH, et al. A meta-analysis of low- density lipoprotein cholesterol, non-high-density lipoprotein choles- terol, and apolipoprotein B as markers of cardiovascular risk. Circ Cardiovasc Qual Outcomes. 2011;4:337 45. S4.3-34. Budoff MJ, Young R, Burke G, et al. Ten-year association of coronary artery calcium with atherosclerotic cardiovascular disease (ASCVD) events: the multi-ethnic study of atherosclerosis (MESA). Eur Heart J. 2018;39:2401 8. S4.3-35. Cholesterol Treatment Trialists (CTT) CollaboratorsMihaylova B, Emberson J, et al. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet. 2012;380: 581 90. S4.3-36. Huo X, Gao L, Guo L, et al. Risk of non-fatal cardiovascular diseases in early-onset versus late-onset type 2 diabetes in China: a cross- sectional study. Lancet Diabetes Endocrinol. 2016;4:115 24. S4.3-37. Svensson MK, Cederholm J, Eliasson B, et al. Albuminuria and renal function as predictors of cardiovascular events and mortality in a general population of patients with type 2 diabetes: a nationwide observational study from the Swedish National Diabetes Register. Diab Vasc Dis Res. 2013;10:520 9. S4.3-38. Guo VY, Cao B, Wu X, et al. Prospective association between dia- betic retinopathy and cardiovascular disease a systematic review and meta-analysis of cohort studies. J Stroke Cerebrovasc Dis. 2016;25:1688 95. S4.3-39. Brownrigg JRW, de Lusignan S, McGovern A, et al. 